Metabolic basis for disorders of purine nucleotide degradation
dc.contributor.author | Fox, Irving H. | en_US |
dc.date.accessioned | 2006-04-07T18:05:58Z | |
dc.date.available | 2006-04-07T18:05:58Z | |
dc.date.issued | 1981-06 | en_US |
dc.identifier.citation | Fox, Irving H. (1981/06)."Metabolic basis for disorders of purine nucleotide degradation." Metabolism 30(6): 616-634. <http://hdl.handle.net/2027.42/24368> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WN4-4C2S7YX-6F/2/8efa80567af4ff49b7ba70b0c602507c | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24368 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6262603&dopt=citation | en_US |
dc.description.abstract | Purine nucleotide degradation refers to a regulated series of reactions by which human purine ribonucleotides and deoxyribonucleotides are degraded to uric acid in humans. Two major types of disorders occur in this pathway. A block of degradation occurs with syndromes involving immune deficiency, myopathy or renal calculi. Increased degradation of nucleotides occurs with syndromes characterized by hyperuricemia and gout, renal calculi, anemia or acute hypoxia. Management of disorders of purine nucleotide degradation is dependent upon modifying the specific molecular pathology underlying each disease state. | en_US |
dc.format.extent | 2403611 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Metabolic basis for disorders of purine nucleotide degradation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Human Purine Research Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Department of Biological Chemistry, Clinical Research Center, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 6262603 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24368/1/0000637.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0026-0495(81)90142-6 | en_US |
dc.identifier.source | Metabolism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.